Amy J Sehnert

13PUBLICATIONS
40CO-AUTHORS
Cardiology (incl. cardiovascular diseases)PharmacogenomicsMedical biotechnology diagnostics (incl. biosensors)Respiratory diseasesCell physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Nov 18, 2024
Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results From VALOR-HCM.

Milind Y Desai, Kathy Wolski, Anjali Owens

|Sep 02, 2024
Serial Changes in Ventricular Strain in Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten: Insights From the VALOR-HCM Trial.

Milind Y Desai, Yuichiro Okushi, Andrew Gaballa

|Aug 29, 2024
Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Rationale for Clinically Guided Dose Titration to Optimize Individual Response.

Anjali T Owens, Milind Desai, Matthew T Wheeler

|Aug 13, 2024
Characterization of mavacamten pharmacokinetics in patients with hypertrophic cardiomyopathy to inform dose titration.

Peter Chang, Vidya Perera, David H Salinger

|May 02, 2024
Recommendation of mavacamten posology by model-based analyses in adults with obstructive hypertrophic cardiomyopathy.

Samira Merali, David H Salinger, Maria Palmisano

|Apr 09, 2024
Long-Term Safety and Efficacy of Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results of the PIONEER-OLE Study.

Ahmad Masri, Steven J Lester, John C Stendahl

Pageof 3

Frequent Collaborators

8 joint publications

Sara Saberi

8 joint publications

Andrew Wang

7 joint publications

Anjali T Owens

4 joint publications

Sheila M Hegde